Ms. Julia M. Amadio has been Chief Product Officer at TherapeuticsMD, Inc. since January, 2012. Ms. Amadio has an extensive, 25-year background in general management and leading pharmaceutical marketing and product development organizations. From June 2011 to January 2012, Ms. Amadio served as President of JMA Consulting, LLC, her own consulting company she began in 2008. Ms. Amadio served as a Vice President of Global Marketing - Healthcare Business of MeadWestvaco Corporation from June, 2009 to May 2011 and oversaw marketing and commercialization for growing portfolio of OTC and pharmaceutical packaging solutions, including MWV's successful adherence and compliance product lines. Ms. Amadio was President of a start-up Patients' & Consumers' Pharma in 2007. She founded JMA Consulting, where she conducted commercial assessments and developed marketing and distribution strategies for various U.S.-based and international clients. Ms. Amadio previously held senior marketing and management positions with Parexel MMS, Daiichi, Aventis,Wyeth and J&J. She headed the US launch for Lantus and Actonel, both, multibillion dollar successes. Ms. Amadio has served on various boards and committees throughout her professional career. She was the global director-at-large of the Healthcare Businesswomen's Association (HBA), in addition to President of 2 chapters She was an adjunct lecturer at St. Joseph's University in the pharmaceutical MBA program and authored a chapter on Marketing, Market Research and insights in the book Pharmaceutical Development for Woman (Wiley & Sons). Ms. Amadio holds a Masters of Business Administration from Drexel University and a Bachelor of Science in Accounting from St. Joseph's University in Philadelphia, PA.
Postpartum depression affects 1 in 8 new mothers in the United States
29 Jul 2021Pregnancy & Postpartum
Here’s Why the CDC Recommends Wearing Masks Indoors Even if You’ve Been Fully Vaccinated Against COVID-19
The new guidelines target areas with high infection rates — 63% of U.S. counties on the day the guidelines were announced
29 Jul 2021Your Health
You might be interested in
☆☆☆☆☆ By eMediHealth ☆☆☆☆☆